NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor
Rhea-AI Summary
NewGenIVF (Nasdaq: NIVF) announced that it has completed an exchange agreement with a certain institutional investor, under which the investor’s existing convertible notes were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026.
The restructuring removes a prior mandatory requirement that a significant percentage of proceeds from new capital raises be used to prepay the notes under the June 16, 2026 Repurchase and Forbearance Agreement. The new note also includes a leak-out framework and other modified terms intended to give NewGen greater flexibility in managing future financing. The company said it continues to evaluate additional opportunities to further optimize its capital structure.
Positive
- Exchange of existing notes into a new senior convertible note on amended terms
- Elimination of mandatory proceeds sweep from new capital raises under June 16, 2026 agreement
- New note includes a leak-out framework intended to provide capital structure flexibility
- Company signals ongoing efforts to optimize capital structure consistent with shareholder interests
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 30 | K25.ai investment update | Positive | -0.5% | Stake valuation and expected unrealized gain update contrasted with negative reaction |
| Jul 27 | K25.ai acquisition | Positive | -4.5% | Additional K25.ai stake agreement and projected Nasdaq compliance coincided with decline |
| Jul 23 | K25.ai valuation update | Positive | -3.9% | Series A valuation doubled, implying an unrealized gain for NewGen |
| Jul 23 | K25.ai Series A | Positive | -3.9% | K25.ai Series A financing reached a US$200 million post-money valuation |
| Jul 06 | Cytometry expansion update | Positive | +7.8% | Independent valuation supported planned UAE cell-sorting and cytometry leasing expansion |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive corporate announcements mostly coincided with negative 24-hour reactions, with one positive reaction.
Key Terms
convertible notes financial
senior convertible note financial
mandatory proceeds sweep financial
form 6-k regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Restructuring eliminates prior mandatory proceeds sweep and improves capital structure flexibility
BANGKOK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible notes held by the Investor were exchanged for a new senior convertible note on amended terms. The exchange closed on August 14, 2026.
The restructuring eliminates the prior mandatory requirement that a significant percentage of proceeds from new capital raises be applied to prepay the notes under the Repurchase and Forbearance Agreement dated June 16, 2026, which was disclosed in the Company’s Form 6-K filing on June 16, 2026. The new note also incorporates a leak-out framework and other modified terms intended to provide greater flexibility for the Company. The full agreement will be filed as an exhibit to the Company's Report on Form 6-K, which will be furnished to the U.S. Securities and Exchange Commission simultaneously with this press release.
“This exchange represents an important step in improving the terms of our capital structure,” said Alfred Siu, Founder, Chairman and CEO of NewGen. “By removing the previous mandatory proceeds sweep and establishing more constructive terms, we enhance our ability to manage future financing activity in a manner that better supports the Company’s strategic objectives and long-term growth.”
The Company continues to evaluate additional opportunities to further optimize its capital structure in a manner consistent with shareholder interests.
About NewGen
NewGenIVF Group Limited is a technology-forward, diversified growth company pursuing opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. NewGenIVF’s legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information contained on, or accessible through, the Company’s website is not incorporated by reference into this press release.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, but are not limited to, statements regarding: the anticipated benefits of the exchange of the Investor's existing convertible notes for a new senior convertible note on amended terms, including the elimination of the prior mandatory proceeds sweep and the leak-out framework and other modified terms intended to provide greater flexibility for the Company; the Company's ability to manage future financing activity in a manner that supports its strategic objectives and long-term growth; and the Company's plans to continue evaluating additional opportunities to optimize its capital structure.
These forward-looking statements are based on the Company's current expectations, estimates, projections and assumptions as of the date of this press release and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These risks and uncertainties include, among others: risk relating to the Company's convertible note financing arrangements, including compliance with associated covenants and the risk of default; share dilution and capital markets issuance risk; and liquidity and capital requirements risk. Additional risks are described in the Company's Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.
All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable securities laws.
Contacts
ICR, LLC
Robin Yang
Phone: +1 (212) 537-3847
Email: Newgenivf.IR@icrinc.com
